Director, Chief Executive Officer · BioAge Labs, Inc. · Common Stock
Side
SELL
Value
$4.22M
Shares
233.1K
Price
$18.12
Executed
Jan 13, 2026
Disclosed
Jan 15, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 13 executedJan 15, 2026 disclosed
BIOA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Fortney Kristen filed this Form 4 reporting a open-market sale of BIOA on Jan 13, 2026. It became public on Jan 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Fortney Kristencik:0002032751
Issuer
BioAge Labs, Inc.cik:0001709941
Revision history · 0
No field has changed since this record was first ingested.
